XML 33 R23.htm IDEA: XBRL DOCUMENT
v3.24.4

Summary of Significant Accounting Policies Summary of Significant Accounting Principles (Tables) | 6 Months Ended
--- | ---
Dec. 31, 2024
Accounting Policies [Abstract] |
Schedule of Other Nonoperating Income (Expense) | The following table summarizes the components of other income (expense), net.
| Three Months Ended December 31, |  | Six Months Ended December 31,
| 2024 |  | 2023 |  | 2024 |  | 2023 |  |
Gains (losses) on derivatives not designated as hedging instruments (1) | $ | 33,632 |  |  | $ | (13,668) |  |  | $ | 13,063 |  |  | $ | (5,356) |  |  |
Currency-related (losses) gains, net (2) | (2,107) |  |  | 13,062 |  |  | 6,560 |  |  | 10,363 |  |  |
Other gains | 153 |  |  | 215 |  |  | 563 |  |  | 1,021 |  |  |
Total other income (expense), net | $ | 31,678 |  |  | $ | (391) |  |  | $ | 20,186 |  |  | $ | 6,028 |  |  |
_____________________ (1) Includes realized and unrealized gains and losses on derivative currency forward and option contracts not designated as hedging instruments. For contracts not designated as hedging instruments, we realized gains of $2,981 and $749 for the three and six months ended December 31, 2024, respectively, and losses of $2,539 and $488 for the three and six months ended December 31, 2023, respectively. Refer to Note 4 for additional details relating to our derivative contracts. (2) Currency-related (losses) gains, net primarily relates to significant non-functional currency intercompany financing relationships that we may change at times and are subject to currency exchange rate volatility. In addition, during the three and six months ended December 31, 2023, we recognized gains of $2,230 and $294, respectively, on a cross-currency swap designated as a cash flow hedge which hedges the remeasurement of an intercompany loan. We did not hold any cross-currency swap contracts that were designated as cash flow hedges during the three and six months ended December 31, 2024. Refer to Note 4 for additional details regarding our cash flow hedges.
Schedule of Weighted Average Number of Shares | The following table sets forth the reconciliation of the weighted-average number of ordinary shares.
| Three Months Ended December 31, |  | Six Months Ended December 31,
| 2024 |  | 2023 |  | 2024 |  | 2023 |  |
Weighted average shares outstanding, basic | 24,965,612 |  |  | 26,609,929 |  |  | 25,066,729 |  |  | 26,539,349 |  |  |
Weighted average shares issuable upon exercise/vesting of outstanding share options/PSUs/RSUs/warrants (1) | 940,539 |  |  | 569,144 |  |  | 1,078,723 |  |  | 589,915 |  |  |
Shares used in computing diluted net income per share attributable to Cimpress plc | 25,906,151 |  |  | 27,179,073 |  |  | 26,145,452 |  |  | 27,129,264 |  |  |
Weighted average anti-dilutive shares excluded from diluted net income per share attributable to Cimpress plc | 299,877 |  |  | 192,204 |  |  | 153,799 |  |  | 189,927 |  |  |
__________________ (1) On May 1, 2020, we entered into a financing arrangement which included 7-year warrants to purchase 1,055,377 of our ordinary shares with a strike price of $60 that have a potentially dilutive impact on our weighted average shares outstanding. The weighted average dilutive effect of the warrants for the three and six months ended December 31, 2024 were 248,156 and 294,657, respectively, and for the three and six months ended December 31, 2023 were 146,506 and 122,412, respectively.

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items. + References No definition available. + Details
Name: | us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration